Figure 10A showed that PDCD6, MAL2, SLC25A15, PTDSS1 were prone to mutation in BLCA patients. Figure 10B and 10C revealed the association between the gene mutation and BLCA patients’ OS and DFS. The gene discussed is MAL2; the disease is bladder transitional cell carcinoma.